Week of September 7, 2026 · 10 stocks
Illumina and Everpure ride into the S&P 500 while FICO's moat and Lululemon's guidance both give way
Passive-flow bids collided with two of the year's cleanest blow-ups — a broken credit-scoring monopoly and a third guidance cut — as the meme corner fought Robinhood over tokenized shares.
This week's feed ran roughly 1.08M mentions across about 2,000 names, and once you clear out the cashtag look-alikes — a mining-game token trading as $RIG, a Solana memecoin wearing $BILL, the $PURR and $BOX crypto imposters — the genuine leaderboard split cleanly in two. Half of it is index-rebalance mechanics ahead of the September 21 S&P 500 reshuffle; the other half is a pair of September 4 detonations that took FICO and Lululemon apart on the same afternoon.
At 9,847 posts in seven days and a 2.8x spike, AMC was the loudest genuine equity on the board — and the fuel isn't the box office. CEO Adam Aron spent the week publicly torching Robinhood for listing a tokenized $AMC that trades without any underlying shares, calling it fraud and threatening to bring the SEC into it.
The crowd promptly split down the middle. One camp cheers Aron's fight as validation; another treats the token's fat premium over the $2.54 stock as fresh MOASS fuel. The disagreement is genuine, and the pre-market pop only sharpened it.
The awkward part for the bulls is the cap table: Q2 actually printed cash — $1.6B revenue and $0.14 EPS against a $0.03 estimate — but 892M shares outstanding is the wall every bounce runs into. Volume at 2.2x its 30-day average says the flow is real; the Robinhood storyline is likely a two-week affair, and November earnings is the durability test.
Only 26 posts, but sustained chatter in the 97th percentile — the quiet, high-signal kind. Q2 gave it something to talk about: EPS of $1.79 beat the $1.70 consensus, revenue rose 24% to $119.2M, and VYJUVEK — its topical gene therapy for a rare skin disease — has now cleared $965.9M since launch.
Posts frame it as a pristine cash machine: 95% gross margins, a balance sheet over $1.1B, the durable-growth biotech everyone wishes they'd owned earlier. There's essentially no bear in the sample.
The wrinkle landed September 4. Co-founders Krish and Suma Krishnan each sold roughly $9M the same day — about $18M of coordinated founder-family selling at 90% of the 52-week range — with director Dino Rossi's $8.2M sale on August 14 sitting just ahead of it. The operating cadence backs the chatter; the people who know it best are trimming into it.
Illumina's admission to the S&P 500 on September 21 — replacing Builders FirstSource — is the entire story, and the crowd knows it. Up 66% year-to-date into the event, the DNA-sequencing name drew 251 posts and a 3.5x spike as traders front-run the passive-flow math.
The conversation is almost comically one-directional: index funds are a forced buyer at the close, so why argue. There's no meaningful bear voice in the sample at all.
Which is exactly what makes the quiet number worth flagging. The business has genuinely stabilized — $1.1B a quarter, up 5%, at 68% gross margins after two brutal GRAIL years — but nobody's tweeting the $239M of officer selling with zero open-market buys, the largest insider exit on the whole board, into forced index buying at 92% of the range.
Pure Storage — genuinely $PSTG, not the similarly-named Everpure that also shows up on this week's list — is compounding without much noise. Q4 revenue grew 20% to $1.06B at a 70% gross margin, and the stock is up 62% over the trailing year on the AI and hyperscale storage buildout.
The conversation here is thin and sell-side-flavored rather than a retail pile-on: "priced for perfection," the notes say, before conceding in the same breath that it'll "keep riding the AI hype." Steady institutional interest, not a meme.
The models do the heavy lifting — analysts build toward roughly $4.37B in FY27 revenue and $2.29 EPS — while a 0.15 debt-to-equity ratio and no captured insider selling keep the picture clean. The stock is sitting mid-range near its 50-day: an uptrend digesting recent gains, not breaking out.
BETA Technologies — the Amazon-backed electric-aircraft maker that IPO'd last November — is coiling into an early-October print, with 213 posts, a 7.6x spike, and volume running 1.45x normal. (The $BETA memecoin sharing the symbol is noise; the eVTOL thread is the one doing the work.)
Bulls can't stop citing the stack: a director's roughly $500K open-market buy of about 26,000 shares, sitting on top of Amazon's 5.3% stake and fresh BofA and BNY Mellon disclosures — an insider-plus-strategic-plus-institutional trifecta.
The P&L is pure story for now — $10M in quarterly revenue against a deep cash-burn operating margin — so the market is treating this as a call option on cargo-eVTOL certification rather than a going concern. A certification slip is the honest risk; a firmed Amazon delivery milestone at the October print is what the coil is pricing.
The other S&P 500 ticket punched this week: Everpure joins the index on September 21, replacing The Trade Desk. It logged 401 posts, is up 48.5% year-to-date, and the crowd's whole thesis is the passive bid — the same forced-buyer-at-the-close reflex driving Illumina.
Bulls line it up next to Bloom Energy (+191%) and Illumina as the inclusion trio, with almost no debate beyond the mechanics of getting added.
The fundamentals wave a flag the tweets skip past. Revenue was flat year-over-year at $778M last quarter, down from 20% growth just two quarters earlier, and $54M of officer selling with zero buys landed into the very event insiders had been building toward — at 125x earnings. The flow is real; the growth story it's supposed to reward is stalling.
Alibaba pulled the highest raw volume of any genuine name — 1,836 posts and a 4.2x spike — off a rare insider tell. Chairman Joseph Tsai and CEO Wu Yongming each put down eight-figure open-market purchases in late August, near the tape, following the company's $10B private placement.
The crowd is authentically split. Bulls stack the founder buys against CXMT's HBM3E breakthrough and Qwen Office already at 30M users; frustrated longs quote "owning Chinese stocks in 2026 has to be a humiliation ritual" with the stock still 60% below its all-time high. This is real disagreement, not consensus with a token skeptic.
The numbers demand patience either way — a 2.5x trailing PE looks like a gift until you notice Q1 EPS missed by 36% and free cash flow ran negative $18B. The November 24 print, and whether the T-Head chip supply chain converts to bookings, settles which camp was early.
Fair Isaac cratered roughly 17% on September 4 after FHFA director Bill Pulte ordered Fannie and Freddie to accept VantageScore 4.0 from every lender, effective immediately — ending the decades-old mortgage-scoring monopoly the stock's multiple was built on. It drew 445 posts and now sits about 53% below its 52-week high.
Bears own the sample, and the detail they keep resurfacing stings: VantageScore lists at under $1 against FICO's $10-plus, after roughly 1,800% of price hikes since 2020. The lone bull reply — "third time this headline's run, it faded twice before" — is getting shouted down, because this time it's an executed directive to the GSEs, not a proposal.
The irony is that the business was never the problem: 39% revenue growth, an 84% gross margin, a franchise-quality print. But 35x earnings was underwriting a moat that just took a hole. Down 38% year-to-date at 5% of its range on 4x volume — the tape has already voted.
Lululemon's third guidance cut of 2026 dropped on September 3 and dragged the stock roughly 18% lower to an eight-year low under $100. The full-year revenue guide has walked steadily downhill all year — from $11.35–11.50B in March to $10.35–10.50B now — with each cut following a quarter that beat on EPS but missed on the growth that matters.
The dominant thread isn't even the company — it's Michael Burry, whose LULU became his largest position and now his largest loss. He called it a "fat pitch below $100" and said he's buying more; the "no moat, brutal competition" bloc is out in force mocking the call.
The data cuts the way the bears like: consensus already models revenue flat-to-down for three years, founder Chip Wilson's 13D activism hasn't forced a change, and the AI/tech officer just left. Zero debt and $1.3B in cash is the only real card the contrarians are holding.
Webull — which, fittingly, trades as $BULL — is the beta play on "retail trading is back," rerating alongside Robinhood and IBKR through the summer. It logged 2,422 posts and a 3.3x spike, with traders openly circling a close above $10 as the trigger for the next leg.
The bull case is running nearly unopposed: the best quarter the company's reported, a Coinbase custody expansion into Canada, and Q2 EPS of $0.07 that beat by 56%. Every covering analyst rates it a buy — which, as Zacks dryly noted, tends to cap upside more than confirm it.
The tape is cooperating: 24% above the 50-day, 36% above the 200-day, and orderly at a 0.58 beta. Two officers trimmed about $475K each into the rally — a small tell, not a big one. The whole thesis rests on retail volumes holding into the November 19 print; a market pullback that quiets the flow is the direct hit.
The imposters got left at the door — the mining-game token wearing $RIG, the Solana memecoin as $BILL, the $PURR and $BOX crypto look-alikes. For the real leaderboard, the mention velocity, and the per-name breakdown, the live board updates daily at tickertalks.ai. Research tool, not financial advice — the decision is yours.
Want this live, not weekly?
See what's trending right now →TickerTalks is a research tool, not financial advice. This recap describes what accounts on X are discussing — it is not a recommendation to buy or sell any security. Social attention is not predictive of future price moves; investing involves risk of loss.
